Over the years Starpharma have accumulated losses of about $230 million
The current market cap is around $60 million
The accumulated losses are almost 4 times current share value
The amount of money spent on trials has been in excess of $150 million
The IP is worth substantially more than how the market has priced it
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
10.0¢ |
Change
-0.005(4.76%) |
Mkt cap ! $41.82M | |||
| Open | High | Low | Value | Volume |
| 10.5¢ | 10.5¢ | 10.0¢ | $22.95K | 227.0K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 3 | 222825 | 10.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 10.5¢ | 56010 | 3 |
View Market Depth
| Last trade - 15.18pm 21/07/2025 (20 minute delay) ? |
| SPL (ASX) Chart |